Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Procurement (DP) and Hypothermic Oxygenated Perfusion (HOPE) of Donor Hearts After Circulatory Death (DCD) Using the XVIVO Heart Assist Transport System

NCT06485596 is registered in ClinicalTrials.gov with XVIVO Perfusion as lead sponsor.

NCT NCT06485596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06485596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Procurement (DP) and Hypothermic Oxygenated Perfusion (HOPE) of Donor Hearts After Circulatory Death (DCD) Using the XVIVO Heart Assist Transport System
Lead sponsor
XVIVO Perfusion
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 3, 2024
Completion date
August 31, 2026
Enrollment
40 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure